Cargando…
High-Dose Intravenous Steroid Treatment Seems to Have No Long-Term Negative Effect on Bone Mineral Density of Young and Newly Diagnosed Multiple Sclerosis Patients: A Pilot Study
High-dose intravenous steroid treatment (HDIST) represents the first choice of treatment for multiple sclerosis (MS) relapses. Chronic oral glucocorticoid (GC) administration correlates with bone loss whereas data regarding HDIST in MS are still conflicting. Twenty-five newly diagnosed MS patients (...
Autores principales: | Simeakis, George, Anagnostouli, Maria, Fakas, Nikolaos, Koutsikos, John, Papatheodorou, Athanasios, Chanopoulos, Konstantinos, Athanasiou, Kwnstantinos, Papatheodorou, George, Zapanti, Evangelia, Alevizaki, Maria, Kaltsas, Gregory, Terpos, Evangelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952957/ https://www.ncbi.nlm.nih.gov/pubmed/36831140 http://dx.doi.org/10.3390/biomedicines11020603 |
Ejemplares similares
-
Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection
por: Markoglou, Nikolaos, et al.
Publicado: (2022) -
Medullary thyroid carcinoma (MTC): unusual metastatic sites
por: Kazakou, Paraskevi, et al.
Publicado: (2021) -
Angiogenic cytokines profile in smoldering multiple myeloma: No difference compared to MGUS but altered compared to symptomatic myeloma
por: Gkotzamanidou, Maria, et al.
Publicado: (2013) -
Familial MTC with RET exon 8 Gly533Cys mutation: origin and prevalence of second malignancy
por: Saltiki, Katerina, et al.
Publicado: (2017) -
Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with multiple myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2020)